NeuroRad TractsNeuroradiology education
Search→Residents→Fellowship→Explore Research↗Anatomy Lab↗Neuroradiology Oral Boards→
Head & Neck

Vasoformative Anomalies: Tumor or Malformation, Then Flow

Fellowship-level neuroradiology teaching by E. Brooke Schrickel, MD. Open this topic in the interactive reading room →

Watch · concise explainerVisual summary

Core clinical idea

The whole field is one fork: tumor or malformation, and within malformations, what flow. That sort dictates treatment — medical (propranolol/steroid) for infantile hemangioma, laser for capillary stain, sclerotherapy for venous and macrocystic lymphatic, excision for microcystic lymphatic, embolization/surgery for AVM. Read by flow + enhancement + timing, and keep a slow/no-flow malformation from being misread as an AVM. MR is the workhorse; CT adds little in the head and neck.

Bottom line

Tumor vs malformation, then sort by flow and enhancement — because each box maps to a different treatment, and a slow-flow lesion misread as an AVM gets the wrong one.

Core workstation questions

  • Tumor or malformation? Present at birth (congenital hemangioma) or appeared in the first weeks then involuting (infantile hemangioma)?
  • High-flow (flow voids + tangle + thrill = AVM) or low-flow (venous, lymphatic)?
  • Does the center enhance? (Enhancing = venous; non-enhancing center with peripheral rim = lymphatic.)
  • Phleboliths (venous) or fluid-fluid/hematocrit levels (lymphatic that bled)?
  • Are flow voids being over-read as AVM when timing/shunting/enhancement actually say congenital hemangioma?
  • Is residual MR enhancement just post-sclerotherapy (weeks-long), not failure?

What changes reporting / management

  • Name 'proliferating infantile hemangioma' to point toward medical therapy (propranolol/steroids); reserve embolization for large lesions risking Kasabach-Merritt.
  • Distinguish congenital hemangioma (present at birth, GLUT1-negative, no shunting, moderate enhancement) from AVM so flow voids don't trigger the wrong embolization/surgery.
  • Use the non-enhancing center to call lymphatic malformation vs the enhancing venous malformation; route macrocystic LM to sclerotherapy, microcystic LM to excision (laser contraindicated).
  • Warn that a sclerosed venous malformation can show MR enhancement/signal for roughly 6-8 weeks — not treatment failure.

Practical traps

  • Misreading a slow-flow congenital hemangioma or venous malformation as a high-flow AVM (sends to wrong intervention).
  • Calling residual post-sclerotherapy enhancement a treatment failure.
  • Treating flow voids alone as diagnostic of AVM.
  • Mislabeling a non-dye-laser-responsive flat lesion as a port-wine stain when it's a congenital hemangioma.

Teaching pearls

  • Infantile hemangioma appears after birth and involutes — and it's a drug (propranolol/steroid), not a knife.
  • Flow voids alone aren't an AVM — present-at-birth, no shunting, modest enhancement is a congenital hemangioma.
  • Non-enhancing center = lymphatic; enhancing center = venous.
  • The lymphatic malformation is the one that bleeds — look for fluid-fluid levels.
  • A sclerosed venous malformation can enhance for weeks; that's not treatment failure.
  • Port-wine stain is flat and laser-responsive; if dye laser doesn't work as expected, doubt the diagnosis.

Teaching visuals

Vasoformative anomalies of the head & neck: sort it, then read the MRI (and beware CT)One fork: TUMOR vs MALFORMATION — within malformations, sort by FLOW. The sort dictates treatment.1 · The sort treeEach box maps to a different treatmentTUMORSInfantile hemangiomaAPPEARS after birth, then involutes · GLUT1 +Treat medically (propranolol/steroid) — not a knifeCongenital hemangiomaPRESENT at birth · GLUT1 − · no shuntingModerate enhancementMALFORMATIONS — sort by FLOWSLOW-FLOWCapillary — stainVENOUS — phleboliths · ENHANCES · fills slowlyLYMPHATIC — macrocystic = fluid-fluid levels;NON-enhancing cyst contents/centre · microcysticLymphatic is the one that bleeds — look for fluid-fluid levelsFAST-FLOWAVM / AV fistulaFLOW VOIDS · shuntlittle/no soft-tissue massFlow voids alone ≠ AVM2 · Read it on MRISequences: T2 (± fat-sat) · post-contrast T1 · look for fluid-fluid levelsAxial neck · T2lobulated T2-brightmass, lateral spacefluid-fluid levelsT2 — bright, lobulatedFLUID-FLUID LEVELS → lymphatic (also venous)PHLEBOLITHS = T2-dark round foci → venousFLOW VOIDSHigh-flow → AVMShunt, little soft-tissue massEnhancement pattern — the centre decidesEnhancing centre = VENOUS (venous enhances)Non-enhancing centre = LYMPHATIC (cyst contents don’t enhance)3 · The CT pitfallDon't commit to “solid tumor” on CT aloneCT ALONE can misleadA venous or lymphatic malformation can looklike a SOLID enhancing soft-tissue MASS —esp. with NO phleboliths & NO fluid-fluid levelsMRI makes the callT2 + post-contrast, ± fluid-fluid levelsBottom lineTumor vs malformation, then sort by flow — each box maps to a different treatment. Flow voids alone aren't an AVM.Enhancing centre = venous; non-enhancing centre = lymphatic (the one that bleeds — look for fluid-fluid levels).On CT alone, a vascular malformation can masquerade as a solid tumor.
Vasoformative Anomalies — Sort It, Read the MRI, Beware CT

Source lectures

  • Vasoformative Anomalies of the Head and Neck

Educational material for radiology residents and neuroradiology fellows. Nothing here drives individual patient care, and it contains no patient data.